{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-041055","form_type":"8-K","ticker":"INBS","cik":"0001725430","company_name":"INTELLIGENT BIO SOLUTIONS INC.","filed_at":"2026-09-01T21:10:28+00:00","discovered_at":"2026-09-01T21:12:03.050961+00:00","generated_at":"2026-09-01T21:12:07.423410+00:00","sec_items":["7.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"INBS reports 98.2% accuracy in codeine drug screen study; 510(k) submission on track for Sept 2026","bullets":["Multi-site study across 3 U.S. clinical sites: 98.2% accuracy, 94.6% sensitivity, 100% specificity for opiate codeine.","Improvement from prior Nov 2024 study: ~94% accuracy and 82% sensitivity; specificity unchanged at 100%.","Results measured against validated LC-MS/MS reference method; 70 true positives, 144 true negatives, 0 false positives.","Company accelerated filing timeline; expects to submit 510(k) application in September 2026 for U.S. market entry.","CEO Harry Simeonidis: 'we now have everything we need for our 510(k) submission.'"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-041055","json":"https://secwatch.observer/filing/0001493152-26-041055.json","markdown":"https://secwatch.observer/filing/0001493152-26-041055.md","text":"https://secwatch.observer/filing/0001493152-26-041055.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1725430/000149315226041055/0001493152-26-041055-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1725430/000149315226041055/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-01T21:12:07.423410+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}